Reversal of H1N1 influenza virus-induced apoptosis by silver nanoparticles functionalized with amantadine

RSC Advances ◽  
2016 ◽  
Vol 6 (92) ◽  
pp. 89679-89686 ◽  
Author(s):  
Yinghua Li ◽  
Zhengfang Lin ◽  
Mingqi Zhao ◽  
Min Guo ◽  
Tiantian Xu ◽  
...  
Keyword(s):  
Silver Nanoparticles ◽  
Influenza Virus ◽  
H1n1 Influenza ◽  
H1n1 Influenza Virus ◽  
Induced Apoptosis

Reversal of H1N1 influenza virus-induced apoptosis by silver nanoparticles functionalized with amantadine.

scholarly journals The inhibition of H1N1 influenza virus-induced apoptosis by silver nanoparticles functionalized with zanamivir

RSC Advances ◽  
2017 ◽  
Vol 7 (2) ◽  
pp. 742-750 ◽  
Author(s):  
Zhengfang Lin ◽  
Yinghua Li ◽  
Min Guo ◽  
Tiantian Xu ◽  
Changbing Wang ◽  
...  
Keyword(s):  
Silver Nanoparticles ◽  
Influenza Virus ◽  
Virus Infection ◽  
Clinical Application ◽  
Influenza Virus Infection ◽  
H1n1 Influenza ◽  
H1n1 Influenza Virus ◽  
Induced Apoptosis ◽  
Effective Drugs

As one of the most effective drugs for influenza virus infection, clinical application of zanamivir is restricted with the emergence of resistant influenza virus.

Inhibition of H1N1 influenza virus-induced apoptosis by selenium nanoparticles functionalized with arbidol through ROS-mediated signaling pathways

2019 ◽  
Vol 7 (27) ◽  
pp. 4252-4262 ◽  
Author(s):  
Yinghua Li ◽  
Zhengfang Lin ◽  
Guifang Gong ◽  
Min Guo ◽  
Tiantian Xu ◽  
...  
Keyword(s):  
Influenza Virus ◽  
Signaling Pathways ◽  
Clinical Application ◽  
Antiviral Agent ◽  
H1n1 Influenza ◽  
Selenium Nanoparticles ◽  
Drug Resistant ◽  
H1n1 Influenza Virus ◽  
Induced Apoptosis

As an effective antiviral agent, the clinical application of arbidol is limited by the appearance of drug-resistant viruses.

scholarly journals Sequential Seasonal H1N1 Influenza Virus Infections Protect Ferrets against Novel 2009 H1N1 Influenza Virus

2012 ◽  
Vol 87 (3) ◽  
pp. 1400-1410 ◽  
Author(s):  
Donald M. Carter ◽  
Chalise E. Bloom ◽  
Eduardo J. M. Nascimento ◽  
Ernesto T. A. Marques ◽  
Jodi K. Craigo ◽  
...  
Keyword(s):  
Influenza Virus ◽  
H1n1 Influenza ◽  
Cross Reactivity ◽  
Influenza Viruses ◽  
The Novel ◽  
Virus Infections ◽  
H1n1 Influenza Virus ◽  
Virus Shedding ◽  
2009 H1n1 ◽  
Novel H1n1 Influenza

ABSTRACTIndividuals <60 years of age had the lowest incidence of infection, with ∼25% of these people having preexisting, cross-reactive antibodies to novel 2009 H1N1 influenza. Many people >60 years old also had preexisting antibodies to novel H1N1. These observations are puzzling because the seasonal H1N1 viruses circulating during the last 60 years were not antigenically similar to novel H1N1. We therefore hypothesized that a sequence of exposures to antigenically different seasonal H1N1 viruses can elicit an antibody response that protects against novel 2009 H1N1. Ferrets were preinfected with seasonal H1N1 viruses and assessed for cross-reactive antibodies to novel H1N1. Serum from infected ferrets was assayed for cross-reactivity to both seasonal and novel 2009 H1N1 strains. These results were compared to those of ferrets that were sequentially infected with H1N1 viruses isolated prior to 1957 or more-recently isolated viruses. Following seroconversion, ferrets were challenged with novel H1N1 influenza virus and assessed for viral titers in the nasal wash, morbidity, and mortality. There was no hemagglutination inhibition (HAI) cross-reactivity in ferrets infected with any single seasonal H1N1 influenza viruses, with limited protection to challenge. However, sequential H1N1 influenza infections reduced the incidence of disease and elicited cross-reactive antibodies to novel H1N1 isolates. The amount and duration of virus shedding and the frequency of transmission following novel H1N1 challenge were reduced. Exposure to multiple seasonal H1N1 influenza viruses, and not to any single H1N1 influenza virus, elicits a breadth of antibodies that neutralize novel H1N1 even though the host was never exposed to the novel H1N1 influenza viruses.

scholarly journals Individual Antibody and T Cell Responses to Vaccination and Infection with the 2009 Pandemic Swine-Origin H1N1 Influenza Virus

2011 ◽  
Vol 31 (5) ◽  
pp. 900-912 ◽  
Author(s):  
Gillian M. Air ◽  
JingQi Feng ◽  
Tao Chen ◽  
Michelle L. Joachims ◽  
Judith A. James ◽  
...  
Keyword(s):  
Influenza Virus ◽  
T Cell ◽  
T Cell Responses ◽  
H1n1 Influenza ◽  
H1n1 Influenza Virus ◽  
Cell Responses
Sign in / Sign up

Export Citation Format

Share Document